ADVFN - Advanced Financial Network.
HOME» NYSE » P » PFE Stock Price » PFE Stock News

Pfizer Share News

 Pfizer Stock Price
PFE Stock Price
 Pfizer Stock Chart
PFE Stock Chart
 Pfizer Stock News
PFE Stock News
 Pfizer Company Information
PFE Company Information
 Pfizer Stock Trades
PFE Stock Trades

WSJ BLOG/Health: A.M. Vitals: NFL Retirees File Suit on Head Injuries

(This story has been posted on The Wall Street Journal Online's Health Blog at By Stefanie Ilgenfritz Here's what's making health news this morning: NFL Retirees File Single Suit for Head Injuries (WSJ): In the complaint, lawyers for more than 2,300 retired players in 86 suits alleged that for decades the NFL hid the risks of such injuries and ignored mounting evidence of the long-term effects that football-related concussions can have, including dementia and chronic depression. Pfizer Prepares for IPO of Animal Health Unit (WSJ): The New York drug maker also disclosed a new name for the animal-health business, Zoetis, which Pfizer said is based on the root "zo" found in animal-related words such as zoo and zoology. Former Coke Executive Slams 'Share of Stomach' Marketing Campaign (Washington Post): Todd Putnam, a former marketing executive at Coca-Cola, now regrets his work and says it contributed to the nation's obesity problem. 6.6 Million Young Adults on Parents' Health Plans, Survey Says (LA Times): That number, found in a survey by the nonprofit Commonwealth Fund, is far higher than earlier estimates. Arizona Tries to Keep Reins Tight as It Starts Regulating Medical Marijuana (NY Times): In Arizona, dispensaries have to abide by zoning regulations that change from one municipality to the next; applicants must offer detailed plans on how to secure, store and track the marijuana; and they have to offer educational materials and hire a medical director to supervise. Suicide Among U.S. Troops Averaging One a Day in 2012 (USA Today): The 154 suicides for active-duty troops in the first 155 days of the year far outdistance the U.S. forces killed in action in Afghanistan -- about 50% more -- according to Pentagon statistics obtained by the Associated Press. -For continuously updated news from The Wall Street Journal, see at

Stock News for Pfizer (PFE)
07/29/201603:10:00Sanofi Profit Down as Diabetes Drug Sales Slip
07/28/201616:10:00Pfizer Announces Positive Top-Line Results from Pivotal Phase...
07/28/201613:26:00Bristol-Myers Results Boosted by Cancer Drugs -- Update
07/28/201610:00:00Pfizer and Western Oncolytics Announce Immuno-Oncology Research...
07/28/201604:30:00AstraZeneca Posts $3 Million Loss
07/27/201616:00:00Teva, Allergan Get FTC Approval for Generics Purchase
07/27/201613:25:00Pfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics
07/25/201608:30:00Spark Therapeutics and Pfizer Announce Updated Data from First...
07/21/201612:50:00Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/21/201607:30:00Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough...
07/19/201617:14:44Statement of Changes in Beneficial Ownership (4)
07/19/201617:14:44Statement of Changes in Beneficial Ownership (4)
07/19/201617:14:44Statement of Changes in Beneficial Ownership (4)
07/19/201617:14:43Statement of Changes in Beneficial Ownership (4)
07/19/201608:00:00Pfizer Receives World Health Organization Prequalification for...
07/18/201606:15:00ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve W...
07/13/201608:00:00Pfizer Announces the Publication of Final Results from Two Pivotal...
07/12/201619:20:00Amgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12/201619:19:00Correction to Juno to Resume Clinical Trial Article
07/12/201619:18:00Correction to Juno to Resume Clinical Trial Article

Pfizer and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations